MKC

MKC Free Cash Flow

$925.90MTTM · USD

Period ending:

MKC FY Free Cash FlowUSD
MKC FY Free Cash Flow1989-11-30: $12.60M1990-11-30: $13.80M1991-11-30: $1.20M1992-11-30: $38.00M1993-11-30: $4.50M1994-11-30: -$15.20M1995-11-30: -$22.70M1996-11-30: $127.00M1997-11-30: $137.30M1998-11-30: $80.30M1999-11-30: $180.00M2000-11-30: $148.40M2001-11-30: $92.40M2002-11-30: $113.00M2003-11-30: $99.20M2004-11-30: $279.70M2005-11-30: $265.40M2006-11-30: $226.00M2007-11-30: $146.00M2008-11-30: $228.80M2009-11-30: $333.40M2010-11-30: $298.50M2011-11-30: $243.30M2012-11-30: $344.70M2013-11-30: $365.30M2014-11-30: $370.90M2015-11-30: $461.60M2016-11-30: $504.30M2017-11-30: $632.90M2018-11-30: $652.10M2019-11-30: $773.10M2020-11-30: $816.00M2021-11-30: $550.30M2022-11-30: $389.50M2023-11-30: $973.40M2024-11-30: $647.00M2025-11-30: $740.40M$973.40M-$22.70M
1989-11-302025-11-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MKC free cash flow history

Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 37 observations from Nov 30, 1989 to Nov 30, 2025.

McCormick & Company Free Cash Flow — Annual fiscal periods (USD)
Period endingFree Cash Flow (USD)
740,400,000
647,000,000
973,400,000
389,500,000
550,300,000
816,000,000
773,100,000
652,100,000
632,900,000
504,300,000
461,600,000
370,900,000
365,300,000
344,700,000
243,300,000
298,500,000
333,400,000
228,800,000
146,000,000
226,000,000
265,400,000
279,700,000
99,200,000
113,000,000
92,400,000
148,400,000
180,000,000
80,300,000
137,300,000
127,000,000
-22,700,000
-15,200,000
4,500,000
38,000,000
1,200,000
13,800,000
12,600,000

Compare free cash flow

Other companies in Consumer Defensive. Each page shows its own reporting periods and currency.

All MKC financial metrics · MKC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.